Alkem Laboratories quarterly results and financials

Alkem Laboratories (ALKEM)₹5,399+1.78%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Alkem Laboratories reported sales of ₹3,744 Cr, up 11.0% from Jun 2025, and net profit of ₹522 Cr, down 22.0% year on year. For the year to Mar 2026, sales were ₹14,712 Cr and net profit ₹2,360 Cr.

Sales (Jun 2026): ₹3,744 Cr
Net profit (Jun 2026): ₹522 Cr
Sales (FY Mar 2026): ₹14,712 Cr
Net profit (FY Mar 2026): ₹2,360 Cr
EPS (Jun 2026): ₹43.46
Borrowings (Mar 2026): ₹2,047 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Alkem Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Alkem Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	3,441	3,327	2,938	3,031	3,416	3,376	3,147	3,372	4,000	3,739	3,603	3,744
Expenses	2,683	2,606	2,528	2,415	2,653	2,607	2,743	2,622	3,068	2,898	3,074	2,966
Operating Profit	747	708	402	609	753	760	391	739	920	828	517	766
OPM %	22.1%	21.1%	14.1%	20.1%	22.1%	23.1%	12.1%	22.1%	23.1%	22.1%	14.1%	20.1%
Other Income	6.01	41.97	75.99	120	134	93.03	146	149	104	89.98	65.05	153
Interest	30.07	25.08	27.06	29.09	28.07	36.10	28.10	30.07	35.11	42.09	54.15	47.10
Depreciation	74.14	70.09	83.07	80.08	79.09	85.10	112	88.05	94.08	95.14	106	100
Profit before tax	647	654	366	617	778	729	395	769	894	779	422	770
Tax %	5.0%	8.0%	17.1%	11.0%	10.0%	12.0%	18.1%	13.1%	13.0%	16.0%	40.0%	32.0%
Exceptional items	−44.11	−42.11	−10.02	0.00	0.00	0.00	0.00	11.03	0.00	−41.11	−80.19	0.00
Net Profit	617	606	305	552	705	643	323	670	782	656	252	522
EPS (Rs)	51.87	49.72	24.53	45.54	57.55	52.29	25.54	55.54	63.94	53.16	19.77	43.46

Alkem Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Alkem Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	4,904	5,692	6,404	7,363	8,350	8,865	10,633	11,603	12,677	12,977	14,712	15,087
Expenses	4,025	4,671	5,377	6,213	6,844	6,895	8,546	9,940	10,394	10,419	11,661	12,006
Operating Profit	866	1,001	1,009	1,120	1,477	1,944	2,053	1,622	2,249	2,512	3,005	3,031
OPM %	18.1%	18.1%	16.1%	15.1%	18.1%	22.1%	19.1%	14.1%	18.1%	19.1%	20.1%	20.1%
Other Income	227	110	115	81.98	102	230	146	101	186	494	407	412
Interest	71.18	45.14	55.15	55.18	65.19	59.14	52.11	107	112	122	161	178
Depreciation	93.17	101	143	193	253	275	304	310	299	357	383	396
Profit before tax	926	962	924	952	1,257	1,837	1,840	1,302	2,018	2,519	2,866	2,865
Tax %	19.1%	6.0%	31.1%	19.0%	9.0%	12.0%	9.0%	23.0%	10.1%	12.1%	18.0%	—
Exceptional items	−10.02	−2.01	0.00	−4.01	1.01	30.05	−10.02	−89.22	−99.17	6.01	−138	−121
Net Profit	754	908	640	776	1,153	1,622	1,686	1,011	1,818	2,224	2,360	2,212
EPS (Rs)	61.97	74.60	52.72	63.59	94.13	132.51	137.57	82.27	150.08	180.84	192.44	180.33
Dividend payout %	19.9%	20.0%	25.0%	24.9%	26.9%	22.9%	24.9%	60.9%	26.9%	24.9%	27.9%	—

Alkem Laboratories balance sheet

₹ crore, at each year end.

Alkem Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	24.05	24.05	24.04	24.05	24.03	24.04	24.05	24.05	24.05	24.06	24.05	24.03
Reserves	2,972	3,662	4,435	4,828	5,401	6,129	7,341	8,607	9,016	10,278	11,947	13,771
Borrowings	1,306	658	659	998	943	1,617	1,707	2,671	1,398	1,420	1,380	2,047
Other Liabilities	991	1,190	1,447	1,812	1,833	2,179	2,447	2,776	3,331	3,862	4,346	5,015
Total Liabilities	5,293	5,534	6,566	7,660	8,202	9,950	11,519	14,078	13,769	15,585	17,697	20,857
Fixed Assets	1,369	1,445	1,790	2,275	2,520	2,897	2,782	2,893	2,672	2,863	2,843	3,857
CWIP	111	172	298	380	491	362	392	338	322	159	546	281
Investments	482	510	554	445	324	262	334	372	623	485	1,849	1,871
Other Assets	3,331	3,408	3,922	4,560	4,866	6,428	8,012	10,476	10,152	12,079	12,459	14,848
Inventories	783	908	1,204	1,438	1,498	1,815	2,308	3,002	2,602	2,658	2,918	3,328
Trade receivables	529	569	717	1,084	1,251	1,654	1,612	1,891	2,139	2,259	2,472	2,990
Cash & equivalents	789	779	398	575	660	1,089	1,984	2,573	2,612	1,574	1,559	1,728
Total Assets	5,293	5,534	6,566	7,660	8,202	9,950	11,519	14,078	13,769	15,585	17,697	20,857

Alkem Laboratories cash flow

₹ crore, for each year.

Alkem Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	324	725	470	266	779	584	1,263	1,110	1,681	1,945	1,911	1,959
Cash from investing activity	−235	205	−294	−350	−318	−736	−993	−1,431	120	−1,009	−1,285	−1,679
Cash from financing activity	−52.22	−931	−138	85.32	−380	79.30	−273	382	−1,767	−1,148	−814	−505
Net cash flow	38.86	2.99	39.86	0.00	81.74	−72.73	−1.99	57.81	41.85	−206	−185	−221
Capex	138	257	645	684	530	363	195	339	233	259	676	618
Free cash flow	190	473	−163	−412	254	237	1,117	784	1,456	1,765	1,281	1,480
CFO / OP %	101.0%	107.0%	73.1%	47.0%	92.0%	59.0%	86.0%	73.0%	121.1%	105.1%	96.0%	86.0%

Alkem Laboratories ratios

Working-capital days and returns, by year.

Alkem Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	51	41	45	61	61	71	65	64	66	64	68	73
Inventory days	169	169	198	221	186	198	241	262	194	197	224	239
Days payable	102	109	123	148	120	105	113	103	88	130	149	162
Cash conversion cycle	122	104	123	136	130	168	197	226	175	133	146	153
Working capital days	−53	12	33	39	54	43	47	30	65	134	122	122
ROCE %	12.0%	23.0%	21.0%	17.0%	16.0%	18.0%	22.0%	18.0%	14.0%	20.0%	20.0%	21.0%

Alkem Laboratories: frequently asked questions

What are the latest quarterly results of Alkem Laboratories?

For the Jun 2026 quarter, Alkem Laboratories reported sales of ₹3,744 Cr, up 11.0% year on year and net profit of ₹522 Cr, down 22.0% year on year. The operating margin was 20.1%.

What is the annual revenue of Alkem Laboratories?

Alkem Laboratories' sales for the year to Mar 2026 were ₹14,712 Cr; over the last twelve months they were ₹15,087 Cr.

What is the net profit of Alkem Laboratories?

Net profit for the year to Mar 2026 was ₹2,360 Cr, and ₹2,212 Cr over the last twelve months. Earnings per share over the same trailing period were ₹180.33.

How much debt does Alkem Laboratories have?

Alkem Laboratories reported borrowings of ₹2,047 Cr at Mar 2026, against cash and equivalents of ₹1,728 Cr.

What is the free cash flow of Alkem Laboratories?

Cash from operations was ₹1,959 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1,480 Cr.

Loading…